Page last updated: 2024-10-22

pimagedine and Corneal Diseases

pimagedine has been researched along with Corneal Diseases in 3 studies

pimagedine: diamine oxidase & nitric oxide synthase inhibitor; an advanced glycosylation end product inhibitor; used in the treatment of diabetic complications; structure
aminoguanidine : A one-carbon compound whose unique structure renders it capable of acting as a derivative of hydrazine, guanidine or formamide.

Corneal Diseases: Diseases of the cornea.

Research Excerpts

ExcerptRelevanceReference

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gül, M1
Emre, S1
Eşrefoğlu, M1
Vard, N1
Yücel, I1
Yücel, G1
Akar, Y1
Demir, N1
Gürbüz, N1
Aslan, M1
Svozílková, P1
Bysterská, P1
Masek, K1
Valenta, Z1
Zvárová, J1
Farghali, H1

Other Studies

3 other studies available for pimagedine and Corneal Diseases

ArticleYear
Protective effects of melatonin and aminoguanidine on the cornea in streptozotocin-induced diabetic rats.
    Cornea, 2008, Volume: 27, Issue:7

    Topics: Administration, Oral; Animals; Antioxidants; Blood Glucose; Body Weight; Corneal Diseases; Diabetes

2008
Transmission electron microscopy and autofluorescence findings in the cornea of diabetic rats treated with aminoguanidine.
    Canadian journal of ophthalmology. Journal canadien d'ophtalmologie, 2006, Volume: 41, Issue:1

    Topics: Animals; Cornea; Corneal Diseases; Diabetes Mellitus, Experimental; Disease Models, Animal; Enzyme I

2006
Comparison of FK 506, mycophenolate mofetil, and aminoguanidine effects on delay of corneal allograft rejection in an experimental model of low-risk and high-risk keratoplasty.
    Immunopharmacology and immunotoxicology, 2006, Volume: 28, Issue:2

    Topics: Animals; Corneal Diseases; Corneal Transplantation; Disease Models, Animal; Drug Combinations; Femal

2006